TLDR: Cary, NC-based PeriGen is at the forefront of improving maternal and fetal outcomes with its AI-powered perinatal software, PeriWatch. This technology provides real-time insights and early warning systems for labor and delivery, leading to reported reductions in complications such as C-sections, operative vaginal deliveries, and unexpected NICU admissions. The company recently received FDA clearance for its Patterns 3.0, further expanding its fetal monitoring capabilities.
Cary, NC – A local firm, PeriGen, is making significant strides in enhancing patient safety and reducing complications during childbirth through its innovative artificial intelligence (AI)-powered software solutions. The company, headquartered in Cary, specializes in perinatal technology designed to support quality patient care for mothers and babies.
PeriGen’s flagship products, PeriWatch Surveillance™ and PeriWatch Vigilance®, serve as advanced maternal-fetal surveillance and early warning systems. These platforms integrate sophisticated statistical analysis to boost clinical efficiency and standardize care throughout the childbirth process. By providing consistent, real-time analysis and clear display of complex data, PeriGen’s PeriWatch platform helps healthcare professionals quickly identify and communicate about impending problems during labor. This allows clinicians to dedicate more time to direct patient care, minimizing the need for manual calculations and data manipulation.
The impact of PeriGen’s technology on birth outcomes has been notable. The software has been associated with a reduction in complications such as uterine tachysystole and unexpected Neonatal Intensive Care Unit (NICU) admissions. Furthermore, a study highlighted a significant decrease in cesarean section and operative vaginal delivery rates among patients monitored with continuous remote fetal monitoring, a capability enhanced by PeriGen’s systems.
PeriGen recently achieved a significant milestone with the FDA clearance of its Patterns 3.0, which expands its AI-powered fetal monitoring capabilities to 32 weeks. This regulatory approval underscores the system’s reliability and its potential to further improve perinatal care.
Healthcare professionals using PeriGen’s solutions have lauded its effectiveness. Natalie Nicholson, Director of Nursing at Renown Health, stated, “Before PeriGen, we looked at long streams of paper to discern if one data point was cause for intervention, making it difficult to identify worrisome trends quickly. Now, we have several hours of information at our fingertips, along with the analytics to add further context.” Tammy Jerz, Manager of the Birthplace at Spectrum Health Lakeland, emphasized the transformative potential, saying, “I think in a few years hospitals without AI in obstetrics will be lagging behind.” Dr. Kent Bishop, Chief Medical Director at ProMedica Physicians and Acute Care, noted the logical application of AI: “Using AI to help our nurses assess and consistently identify irregularities is so logical, we considered trying to build our own solution; during our research we found a proven system that we can partner with.” Dr. Kimberly McKay, OBGYN at Avera Health, highlighted the system’s alerting mechanisms, which can pull clinicians back to a patient if vital signs indicate a problem, crucial in a busy labor and delivery environment.
Also Read:
- Ketryx Relocates to Expanded Cambridge Headquarters Amid Soaring Demand for AI Compliance Solutions
- Bearing Redefines Corporate Security with Agentic AI on ServiceNow Platform
Founded by skilled OB practitioners and IT visionaries, PeriGen’s software is designed by clinicians, for clinicians, ensuring it complements existing workflows rather than adding burdens. The company, located at 100 Regency Forest Drive, Suite 200, Cary, NC 27518, continues to lead innovation in perinatal care, striving to protect both the patient seen and the patient unseen.
